Gain Therapeutics, Inc. (GANX) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$20.16M | +1.2% |
| 2024 | -$20.41M | +8.3% |
| 2023 | -$22.27M | -26.6% |
| 2022 | -$17.59M | -26.6% |
| 2021 | -$13.89M | -288.3% |
| 2020 | -$3.58M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$20.16M | +1.2% |
| 2024 | -$20.41M | +8.3% |
| 2023 | -$22.27M | -26.6% |
| 2022 | -$17.59M | -26.6% |
| 2021 | -$13.89M | -288.3% |
| 2020 | -$3.58M | — |